Mitsui, Rohto Pharmaceutical take 86% stake in Eu Yan Sang for S$687 million
JAPAN’S Mitsui & Co and Rohto Pharmaceutical have purchased an 86 per cent stake in Eu Yan Sang International for ...
JAPAN’S Mitsui & Co and Rohto Pharmaceutical have purchased an 86 per cent stake in Eu Yan Sang International for ...
A GROUP including Japan’s Mitsui and Rohto Pharmaceutical is nearing a deal to acquire a majority stake in medicine and ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.